Additionally, the HIF1A-AS2/miR-29c/LOX regulatory axis has been shown to promote M2 polarization, enhance immune escape and chemoresistance, and lead to a poor prognosis in GC patients [84]. The gene discussed is HIF1A; the disease is gastric cancer.